Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States

JAMA

Volumn 285, Issue 17, 2001, Pages 2216-2222

  Steinberg, Karen K ^a   Cogswell, Mary E ^b   Chang, Joy C ^a   Caudill, Samuel P ^a   McQuillan, Geraldine M ^c   Bowman, Barbara A ^b   Grummer Strawn, Laurence M ^b   Sampson, Eric J ^a   Khoury, Muin J ^a   Gallagher, Margaret L ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN C282Y; PROTEIN H63D; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ETHNOLOGY; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

EID: 0035795607     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.17.2216     Document Type: Article

References (41)

1. Molecular medicine and hemochromatosis: At the crossroads
2. Iron overload, public health, and genetics
3. Diagnosis of hemochromatosis
4. Management of hemochromatosis
5. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
6. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor
7. The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells
8. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding
9. Hereditary hemochromatosis: Gene discovery and its implications for population-based screening
10. Mutational analysis in the HFE gene inpatients with hereditary haemochromatosis in Saquenay-Lac-Saint-Jean (Quebec, Canada)
11. Prevalence of the HFE Cys282Tyr mutation of the haemochromatosis gene (GH) in Cantabria
12. Prevalence of the C282Y and H63D mutations in the HPE gene in patients with hereditary haemochromatosis and in control subjects in northern Germany
13. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hemochromatosis and controls
14. Hereditary haemochromatosis mutation frequencies in the general population
15. HFE genotype in patients with hemochromatosis and in patients with liver disease
16. Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri
17. The haemochromatosis gene: A global perspective and implications for the Asia-Pacific region
18. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo and its phenotypic expression
19. Mutation analysis in hereditary hemochromatosis
20. DNA banking in epidemiologic studies
21. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94
22. Plan and operation of the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994): Reference manuals and reports
23. Informed consent for genetic research on stored tissue samples
24. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
25. Towards fully automated genome-wide polymorphism screening
26. A cheaper and more rapid polymerase chain reaction-restriction fragment length polymorphism method for the detection of the HLA-H gene mutations occurring in hereditary hemochromatosis
27. A population study of the clinical expression of the hemochromatosis gene
28. The significance of haemochromatosis gene mutations in the general population
29. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic
30. Prevalence of the C282Y and H63D polymorphisms in a multi-ethnic control population
31. Global prevalence of putative haemochromatosis mutations
32. Evidence from a Ghanaian population of known African descent to support the proposition that hemochromatosis is a Caucasian disorder
33. Iron overload in urban Africans in the 1990s
34. The hemochromatosis 845 G→A and 187 C→G mutations: Prevalence in non-Caucasian populations
35. Iron overload disorders among Hispanics in San Diego, California, 1995
36. Prevalence of elevated serum transferrin saturation in adults in the United States
37. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors